Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CYANOTECH CORP
Report date November 08, 2019 · Filed November 12, 2019
Section 16 reporting ended · disclosed 2019-11-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,161 |
Ending reported balance
After 2019-11-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-11-08 · Grant · Acquired 5,700 · Balance 26,605 F1: Grant of shares made pursuant to the Separation Agreement between the issuer and the reporting person, dated as of June 3, 2019 (the "Separation Agreement"), a copy of which is attached to and made a part of the issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 7, 2019; transaction exempt from Section 16(b) of the Securitities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16b-3 thereunder. Row 2 · 2019-11-08 · Disposition to issuer · Disposed 1,444 · Balance 25,161 F2: Shares withheld pursuant to the Separation Agreement to satisfy tax withholding obligations; transaction exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $3.35 | Direct | 75,000 |
Reported balance
Holding disclosure · report date 2019-11-08 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 75,000 F3: Pursuant to Separation Agreement, all stock options are fully vested as of May 22, 2019. F4: Pursuant to Separation Agreement, all stock options will expire on December 6, 2019. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $3.83 | Direct | 45,000 |
Reported balance
Holding disclosure · report date 2019-11-08 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 45,000 F3: Pursuant to Separation Agreement, all stock options are fully vested as of May 22, 2019. F4: Pursuant to Separation Agreement, all stock options will expire on December 6, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of shares made pursuant to the Separation Agreement between the issuer and the reporting person, dated as of June 3, 2019 (the "Separation Agreement"), a copy of which is attached to and made a part of the issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 7, 2019; transaction exempt from Section 16(b) of the Securitities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16b-3 thereunder.
F2: Shares withheld pursuant to the Separation Agreement to satisfy tax withholding obligations; transaction exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder.
F3: Pursuant to Separation Agreement, all stock options are fully vested as of May 22, 2019.
F4: Pursuant to Separation Agreement, all stock options will expire on December 6, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 08, 2019 Filed Nov 12, 2019 16:50 UTC | CYANOTECH CORP CYAN · Entity 8431 | Disposition to issuerCommon Stock | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-022492 · rdgdoc.xml · nonDerivative · entry 2 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,161 F2 · kind: Shares withheld pursuant to the Separation Agreement to satisfy tax withholding obligations; transaction exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 16:50 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-022492 · rdgdoc.xml · nonDerivative · entry 1 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,605 F1 · kind: Grant of shares made pursuant to the Separation Agreement between the issuer and the reporting person, dated as of June 3, 2019 (the "Separation Agreement"), a copy of which is attached to and made a part of the issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 7, 2019; transaction exempt from Section 16(b) of the Securitities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16b-3 thereunder. Read SEC document |
| October 16, 2019 Filed Oct 17, 2019 15:43 UTC | CYANOTECH CORP CYAN · Entity 8431 | Disposition to issuerCommon Stock | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-020192 · rdgdoc.xml · nonDerivative · entry 2 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,905 F2 · kind: Shares withheld pursuant to the Separation Agreement to satisfy tax withholding obligations; transaction exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder. Read SEC document |
| October 16, 2019 Filed Oct 17, 2019 15:43 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-020192 · rdgdoc.xml · nonDerivative · entry 1 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,515 F1 · kind: Grant of shares made pursuant to the Separation Agreement between the issuer and the reporting person, dated as of June 3, 2019 (the "Separation Agreement"), a copy of which is attached to and made a part of the issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 7, 2019; transaction exempt from Section 16(b) of the Securitities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16b-3 thereunder. Read SEC document |
| September 20, 2019 Filed Sep 23, 2019 17:54 UTC | CYANOTECH CORP CYAN · Entity 8431 | Disposition to issuerCommon Stock | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-018915 · rdgdoc.xml · nonDerivative · entry 2 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,815 F2 · kind: Shares withheld pursuant to the Separation Agreement to satisfy tax withholding obligations; transaction exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder. Read SEC document |
| September 20, 2019 Filed Sep 23, 2019 17:54 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-018915 · rdgdoc.xml · nonDerivative · entry 1 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,259 F1 · kind: Grant of shares made pursuant to the Separation Agreement between the issuer and the reporting person, dated as of June 3, 2019 (the "Separation Agreement"), a copy of which is attached to and made a part of the issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 7, 2019; transaction exempt from Section 16(b) of the Securitities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16b-3 thereunder. Read SEC document |
| August 26, 2019 Filed Aug 27, 2019 15:51 UTC | CYANOTECH CORP CYAN · Entity 8431 | Disposition to issuerCommon Stock | 2,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-017508 · rdgdoc.xml · nonDerivative · entry 2 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,559 F2 · kind: Shares withheld pursuant to the Separation Agreement to satisfy tax withholding obligations; transaction exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder. Read SEC document |
| August 26, 2019 Filed Aug 27, 2019 15:51 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-017508 · rdgdoc.xml · nonDerivative · entry 1 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,611 F1 · kind: Grant of shares made pursuant to the Separation Agreement between the issuer and the reporting person, dated as of June 3, 2019 (the "Separation Agreement"), a copy of which is attached to and made a part of the issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 7, 2019; transaction exempt from Section 16(b) of the Securitities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16b-3 thereunder. Read SEC document |
| July 15, 2019 Filed Jul 31, 2019 16:35 UTC | CYANOTECH CORP CYAN · Entity 8431 | Disposition to issuerCommon Stock | 4,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-015054 · rdgdoc.xml · nonDerivative · entry 2 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,911 F2 · kind: Shares withheld pursuant to the Separation Agreement to satisfy tax withholding obligations; transaction exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder. Read SEC document |
| July 15, 2019 Filed Jul 31, 2019 16:35 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantCommon Stock | 11,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-015054 · rdgdoc.xml · nonDerivative · entry 1 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,015 F1 · kind: Grant of shares made pursuant to the Separation Agreement between the issuer and the reporting person, dated as of June 3, 2019 (the "Separation Agreement"), a copy of which is attached to and made a part of the issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 7, 2019; transaction exempt from Section 16(b) of the Securitities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16b-3 thereunder. Read SEC document |
| May 22, 2019 Filed Jul 31, 2019 16:35 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionRestricted Stock Units · Derivative | 1,993 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-015054 · rdgdoc.xml · derivative · entry 5 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: Not disclosed Underlying: Common Stock · 1,993 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: Pursuant to Separation Agreement, all restricted stock units are fully vested as of May 22, 2019. F4 · derivative.expiration_date: Pursuant to Separation Agreement, all restricted stock units are fully vested as of May 22, 2019. Read SEC document |
| May 22, 2019 Filed Jul 31, 2019 16:35 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 411 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-015054 · rdgdoc.xml · nonDerivative · entry 4 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,615 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2019 Filed Jul 31, 2019 16:35 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 1,993 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-015054 · rdgdoc.xml · nonDerivative · entry 3 Morton Mawae · CIK 0001715607 · Former CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2019 Filed Apr 8, 2019 18:36 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionRestricted Stock Units · Derivative | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-006759 · rdgdoc.xml · derivative · entry 2 Morton Mawae · CIK 0001715607 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,993 Underlying: Common Stock · 1,993 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F1 · derivative.exercise_date: The restricted stock units vest as to 653 shares on July 13, 2019; 34 shares on April 5, 2020; 653 shares on July 13, 2020 and 653 shares on July 13, 2021. F1 · derivative.expiration_date: The restricted stock units vest as to 653 shares on July 13, 2019; 34 shares on April 5, 2020; 653 shares on July 13, 2020 and 653 shares on July 13, 2021. Read SEC document |
| April 05, 2019 Filed Apr 8, 2019 18:36 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-006759 · rdgdoc.xml · nonDerivative · entry 1 Morton Mawae · CIK 0001715607 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 13, 2018 Filed Jul 18, 2018 14:58 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantRestricted stock units · Derivative | 1,959 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-013430 · rdgdoc.xml · derivative · entry 1 Morton Mawae · CIK 0001715607 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,959 Underlying: Cyanotech common stock · 1,959 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 653 shares on July 13, 2019, 653 shares on July 13, 2020, and 653 shares on July 13, 2021, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 653 shares on July 13, 2019, 653 shares on July 13, 2020, and 653 shares on July 13, 2021, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 14:55 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantRestricted stock units · Derivative | 67 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006535 · rdgdoc.xml · derivative · entry 2 Morton Mawae · CIK 0001715607 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67 Underlying: Cyanotech common stock · 67 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F4 · derivative.exercise_date: The restricted stock units shall vest as to 33 shares on April 5, 2019 and 34 shares on April 5, 2020, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. F4 · derivative.expiration_date: The restricted stock units shall vest as to 33 shares on April 5, 2019 and 34 shares on April 5, 2020, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. Read SEC document |
| January 24, 2018 Filed Jan 24, 2018 18:58 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantCyanotech common stock options · Derivative | 45,000 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0001437749-18-001095 · rdgdoc.xml · derivative · entry 1 Morton Mawae · CIK 0001715607 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Cyanotech common stock · 45,000 shares Expires 2028-01-24 F1 · derivative.exercise_date: The stock options shall vest as to 15,000 shares on January 24, 2019, 15,000 shares on January 24, 2020 and 15,000 shares on January 24, 2021, in each case subject to continued service with Cyanotech on the vesting date. Read SEC document |
| July 14, 2017 Filed Aug 29, 2017 17:22 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantCyanotech common stock options · Derivative | 75,000 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0001437749-17-015412 · rdgdoc.xml · derivative · entry 1 Morton Mawae · CIK 0001715607 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Cyanotech common stock · 75,000 shares Expires 2027-07-14 F1 · derivative.exercise_date: The stock options shall vest as to 25,000 shares on July 14, 2018, 25,000 shares on July 14, 2019 and 25,000 shares on July 14, 2020, in each case subject to continued service with Cyanotech on the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.